Skip to main content
. 2018 Aug 7;9:645. doi: 10.3389/fneur.2018.00645

Table 1.

Demographic, clinical and sonographic data.

Parkinson's disease
(n = 31)
Essential tremor
(n = 16)
HC
(n = 16)
p-value
Age (years) 69.0 (14.0) 63.5 (21.25) 58.0 (9.25) 0.079H
Female (%)/ 10 (32.3)/ 8 (50)/ 10 (62.5)/ 0.129F
Male (%) 21 (67.7) 8 (50) 6 (37.5)
Time to first suspected disease 9.0 (6.0) 4.5 (9.75) 0.220U
Hoehn and Yahr 2.0 (0)
MDR-UPDRS III 28.0 (14.0) 7.5 (5.0) 0.5 (2.0) <0.001H, b
BDI-II 10.0 (14.0) 12.0 (12.5) 5.0 (8.25) 0.050H, c
LARS −24.0 (15.0) −30.0 (9.0) −31.0 (4.75) <0.001H, b
TCS
Axial SN echogenicity in cm2 (Hyperechogen in %) 0.27 (0.10)
(90.3)
0.14 (0.04)
(12.5)
0.145 (1.0)
(18.8)
<0.001H, a
< 0.001F, a
Reduced BR signal
axial (%)
32.3 6.7 6.3 0.044F, a
Reduced BR signal
coronal (%)
29.0 6.7 6.7 0.119F

Boldface p-values indicate statistical sgnificance. Values are given in median and (interquartile range). MDR-UPDRS, Part 3 of the Movement Disorder Society Unified Parkinson Disease Rating Scale, BDI-II, Becks Depression Inventory II; LARS, Lille Apathy Rating Scale; TCS, Transcranial sonography.

a

Significant difference between the three groups but not between ET patients and HC;

b

Significant difference between the three groups and also between ET patients and HC;

c

Significant difference between the three groups but not between PD and ET patients;

H

Kruskal-Wallis H test;

U

Mann-Whitney-U test;

F

Freeman-Halton extension of Fisher's exact test.